Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Laboratories Ltd.

Division of Mylan NV
mylanlabs.in

Latest From Mylan Laboratories Ltd.

India Coronavirus Actions: Stock Checks, Kaletra Gx Readiness And Bulk Drugs

A string of actions to ensure medicines security and prioritize bulk drug project clearances are underway in India as the country enters a critical phase in its efforts to contain coronavirus cases.

Policy & Regulation Coronavirus COVID-19

Cipla Gears To Step In With Gx Kaletra Supplies For nCoV

Over half a dozen generic versions of AbbVie's Kaletra, currently part of treatment guidelines in China for nCoV-2019, are already on the Indian market and drug maker Cipla says it can make available around 12 million tablets of the combination. India has meanwhile just confirmed its first case of the coronavirus infection.

Generic Drugs Infectious Diseases

Hetero Launches India's First Generic Of Gilead’s Biktarvy

Hetero launches cut-price version of Gilead’s Biktarvy in India but 20 other India-based firms also hold licenses for the product. Gilead is entitled to a “modest royalty” on products produced under the voluntary license.

Launches Strategy

First Generic Of Gilead’s Biktarvy In India Debuts

Hetero launches cut-price version of Gilead’s Biktarvy in India but 20 other India-based firms also hold licenses for the product. Gilead is entitled to a “modest royalty” on products produced under the voluntary license.

Commercial Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Matrix Laboratories Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • B. Hari Babu, PhD, CEO
  • Contact Info
  • Mylan Laboratories Ltd.
    Phone: (91) 40 30866666
    Plot No 564/A/22, Road No. 92
    Jubilee Hills
    Hyderabad , 500034
    India
UsernamePublicRestriction

Register